Adding liraglutide 3.0 mg to lifestyle therapy increases weight loss in obese adolescents, show the findings of a placebo-controlled phase 3 trial.
Research suggests that a single challenge with the neuropeptide kisspeptin can distinguish between children with pubertal delay who will or will not require long-term gonadotropin-releasing hormone therapy.
Children with idiopathic growth hormone deficiency should be retested at mid-puberty, say researchers who found a substantial proportion no longer required growth hormone treatment.
An oral glucose tolerance test may identify youths with a more adverse cardiometabolic profile than a fasting plasma glucose test does, say researchers.
Researchers have identified 10 novel single nucleotide polymorphisms that may help to predict the risk for familial short stature in Han Chinese children.
A case series illustrates the highly variable phenotypes of patients with congenital hypopituitarism caused by SOX3 duplication, and strengthens the association with neural tube defects.
Three-week-old baby referred to the paediatric endocrine clinic from a general paediatrician with ambiguous genitalia, accompanied by very anxious and upset parents.
Giving hydrocortisone four times daily at a time-varying dose may be the best approach for children with congenital adrenal hyperplasia, say the authors of a pharmaco (P)-kinetic and P-dynamic modelling study.
Children with familial short stature (FSS) who have mutations in their C-type natriuretic peptide receptor (NPR2) gene may respond well to growth hormone (GH) therapy, preliminary study findings indicate
Pubertal boys with true gynaecomastia have a significantly higher oestradiol-to-testosterone ratio than those with pseudogynaecomastia or healthy controls, observational study data show.